Study S002747

Evaluation of the Intervention Effect of Yeast Protein Supplementation on Muscle Loss in Individuals Undergoing Weight Loss With Glucagon-Like Peptide-1 Receptor Agonists

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07817823
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 200
Start: 2026-09-20
Primary completion: 2027-03-30
Lead sponsor: Huazhong University of Science and Technology
Conditions: Overweight and Obesity in Adults Receiving GLP-1RA Treatment
Interventions: DIETARY_SUPPLEMENT:Yeast Protein; DIETARY_SUPPLEMENT:Whey Protein; DIETARY_SUPPLEMENT:Yeast Protein/Whey Protein Blend (1:1)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Lean Body Mass From Baseline to Week 12 [Baseline and Week 12]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0004650	Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Eisa N, Diabetes, obesity & metabolism	2026	Systematic review	PMID 41877354 DOI	registry reference RESULT:41877354
R0009502	Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study. Alissou M, Diabetes, obesity & metabolism	2026	Other	PMID 41068996 DOI	registry reference RESULT:41068996